- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 141.11M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $349M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $550.1M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $207.57M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $3.64M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $429.71M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $483.22M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.54B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.5B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.93B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.09B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.52B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.7B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.67B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.85B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 139.3M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $5.87M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$60.41M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $695.38M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $701.68M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.13 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.13 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $26.67M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $26.89M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$17.76M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$13.83M |
| Revenue | Q1 2025 · Mar 31, 2024 | $149.32M |